CarboneC.; PiroG.; TamburrinoA.; MinaM. M.; ZaniniS.; TortoraG.; MelisiD. TGF-β-Activated Kinase 1 (TAK1) Is an In Vivo Druggable Target for Reverting Pancreatic Cancer Chemoresistance. JOP 2013, 14, 562.